1. Home
  2. RYAAY vs ONC Comparison

RYAAY vs ONC Comparison

Compare RYAAY & ONC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RYAAY
  • ONC
  • Stock Information
  • Founded
  • RYAAY 1985
  • ONC 2010
  • Country
  • RYAAY Ireland
  • ONC Switzerland
  • Employees
  • RYAAY N/A
  • ONC N/A
  • Industry
  • RYAAY Air Freight/Delivery Services
  • ONC Biotechnology: Pharmaceutical Preparations
  • Sector
  • RYAAY Consumer Discretionary
  • ONC Health Care
  • Exchange
  • RYAAY Nasdaq
  • ONC Nasdaq
  • Market Cap
  • RYAAY 34.3B
  • ONC 37.3B
  • IPO Year
  • RYAAY 1997
  • ONC N/A
  • Fundamental
  • Price
  • RYAAY $63.47
  • ONC $309.07
  • Analyst Decision
  • RYAAY Strong Buy
  • ONC Strong Buy
  • Analyst Count
  • RYAAY 2
  • ONC 9
  • Target Price
  • RYAAY $67.40
  • ONC $335.78
  • AVG Volume (30 Days)
  • RYAAY 918.2K
  • ONC 328.6K
  • Earning Date
  • RYAAY 07-21-2025
  • ONC 08-06-2025
  • Dividend Yield
  • RYAAY 1.31%
  • ONC N/A
  • EPS Growth
  • RYAAY 34.93
  • ONC N/A
  • EPS
  • RYAAY 2.23
  • ONC N/A
  • Revenue
  • RYAAY $17,216,676,454.00
  • ONC $4,562,002,000.00
  • Revenue This Year
  • RYAAY $9.90
  • ONC $875.58
  • Revenue Next Year
  • RYAAY $5.38
  • ONC $20.99
  • P/E Ratio
  • RYAAY $12.88
  • ONC N/A
  • Revenue Growth
  • RYAAY 9.23
  • ONC 47.33
  • 52 Week Low
  • RYAAY $38.52
  • ONC $170.99
  • 52 Week High
  • RYAAY $67.18
  • ONC $330.63
  • Technical
  • Relative Strength Index (RSI)
  • RYAAY 48.99
  • ONC 59.22
  • Support Level
  • RYAAY $62.27
  • ONC $295.22
  • Resistance Level
  • RYAAY $66.75
  • ONC $320.00
  • Average True Range (ATR)
  • RYAAY 0.96
  • ONC 7.63
  • MACD
  • RYAAY -0.54
  • ONC -1.78
  • Stochastic Oscillator
  • RYAAY 24.44
  • ONC 65.32

About RYAAY Ryanair Holdings plc

Ryanair is Europe's largest low-cost airline, known for its extensive network and highly efficient business model. Operating over 3,600 flights daily across 240-plus destinations in 40 countries, Ryanair has built its success on offering affordable air travel while maintaining tight control over costs. The airline primarily uses Boeing 737 aircraft, including the newer 737 8-200 "Gamechanger" variant, which simplifies operations and reduces expenses. Ryanair focuses on high passenger volume, ancillary revenue, and operational efficiency, ensuring its position as a leading airline in Europe.

About ONC BeiGene Ltd. American Depositary Shares

Founded in 2010 in Beijing and having listed on the Hong Kong exchange in 2018, BeOne is a commercial-stage biotechnology company with global sales. It focuses on oncology therapeutics and differentiates itself from other companies with a contract research organization-free, or CRO-free strategy. BeOne runs global clinical trials with its own team. As of 2024, its core drug is Brukinsa, a small molecule drug for various blood cancers that makes up more than 60% of BeOne's revenue.

Share on Social Networks: